Brazil Pharma Buys Rival

Brazil Pharma Buys Rival

Brazil M&A

Brazilian pharmaceutical retail company Brazil Pharma has moved to acquire its competitor Grupo Big Ben in a transaction valued at BRL453.6m ($259.4m). As structured, the deal involves payment of BRL275m in cash and the rest in ordinary shares of Brazil Pharma, estimated at BRL15.00 per share per the date of the signing. Holders are required to keep the shares for three years. The cash payment is divided into an initial payment of BRL100.9m and three separate payments of BRL58.04m over the next

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial